scholarly journals The relationship between the frequency of the common cold and the activities of natural killer cells

2000 ◽  
Vol 4 (4) ◽  
pp. 212-216 ◽  
Author(s):  
Ming Xu ◽  
Takashi Muto ◽  
Tosio Yabe ◽  
Fumiko Nagao ◽  
Yasushi Fukuwatart ◽  
...  
2014 ◽  
Vol 26 (11) ◽  
pp. 597-606 ◽  
Author(s):  
Masamichi Watanabe ◽  
Yohei Kudo ◽  
Mitsuko Kawano ◽  
Masafumi Nakayama ◽  
Kyohei Nakamura ◽  
...  

2016 ◽  
Author(s):  
Thomas Holst-Hansen ◽  
Elena Abad ◽  
Aura Muntasell ◽  
Miguel López-Botet ◽  
Mogens H. Jensen ◽  
...  

AbstractAllele number, or zygosity, is a clear determinant of gene expression in diploid cells. But the relationship between the number of copies of a gene and its expression can be hard to anticipate, especially when the gene in question is embedded in a regulatory circuit that contains feedbacks. Here we study this question making use of the natural genetic variability of human populations, which allows us to compare the expression profiles of a receptor protein in natural killer cells between donors infected with human cytomegalovirus (HCMV) with one or two copies of the allele. Crucially, the distribution of gene expression in many of the donors is bimodal, indicative of the presence of a positive feedback somewhere in the regulatory environment of the gene. Three separate gene-circuit models differing in the location of the positive feedback with respect to the gene can all reproduce well the homozygous data. However, when the resulting fitted models are applied to the hemizygous donors, only one model (the one with the positive feedback located at the level of gene transcription) reproduces the experimentally observed gene-expression profile. In that way, our work shows that zygosity can help us relate structure and function of gene regulatory networks.Author SummaryNearly all mammalian cells, including human cells, have two copies of each chromosome, and thus possess two potentially different copies of each gene (which might be in some cases non-functional or even absent). Naïively one might expect that two identical copies of the gene would lead to the protein being expressed at twice the rate, but many factors can alter this simple calculation. One of these factors is the existence of feedback mechanisms affecting in one way or another the regulatory circuit in which our gene of interest is embedded. Here we study the relationship between the number of gene copies and the expression of a receptor protein that plays a crucial role in the recognition of pathogens by natural killer cells, which are important elements of the innate immune system. Experimental data of virus-infected donors reveals a bimodal expression profile of this receptor, typical of a positive feedback, and a clear difference between donors with one or two copies of the gene. Mathematical modeling allows us to find the likely location of the feedback loop within the gene’s regulatory circuit, by requiring the correct model to reproduce the expression profiles of both types of donors.


2019 ◽  
Vol 18 ◽  
pp. 153303381989366
Author(s):  
Hui-Qin Luo ◽  
Yi-Fu He ◽  
Wen-Ju Chen ◽  
Ying Yan ◽  
Shu-Sheng Wu ◽  
...  

Objective: The immune makers including CD4+CD25+ T cells, natural killer cells, and T cells subgroup were retrospectively analyzed to find the relationship between apatinib and the immune system in the patients treated with apatinib. Method: Forty-two patients with advanced malignant tumors orally took apatinib as treatment and 16 patients with the same situation did not take apatinib as a control group. These patients were all included in the study, and they orally received apatinib 500 mg daily as monotherapy or combination. The treatment was continued until disease progression or intolerable toxicity. CD4+CD25+ T cells, natural killer cells, and T cells subgroup were detected before and 1 month after therapy for all the patients. The relationship between the changing number of immune cells and progression-free survival was analyzed in this study. Result: For the apatinib group, the rate of CD4+CD25+ T cells significantly increased ( P = .048). The median progression-free survival was 3.25 months for the 42 patients. The median progression-free survival in the patients with the rate of CD4+CD25+ T cells increased and decreased was 5.8 months and 2.9 months, respectively ( P = .012). Multivariate analysis found the increased rate of CD4+CD25+ T cells was an independent prognostic factor for a longer progression-free survival. The rate of natural killer cells and T cells subgroup did not change much after apatinib therapy, and they were not independent prognostic factors for progression-free survival. Conclusion: The rate of CD4+CD25+ T cells is very important in patients with apatinib treatment. The changing number of CD4+CD25+ T cells may be a good indicator for apatinib prognosis. Natural killer cells and T cells subgroup did not change much after apatinib, and they were not independent prognostic factors for progression-free survival.


2015 ◽  
Vol 93 (6) ◽  
pp. 575-580 ◽  
Author(s):  
Imran G House ◽  
Kevin Thia ◽  
Amelia J Brennan ◽  
Richard Tothill ◽  
Alexander Dobrovic ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document